Skip to content

Color Fundus Photograph With Experts Labelling

Development of Digital Fundus Images Dataset of Local Population of Pakistan

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06287645
Enrollment
50000
Registered
2024-03-01
Start date
2022-05-12
Completion date
2026-06-30
Last updated
2024-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy, Retinal Disease

Brief summary

This trial aims to provide a digital retinal image dataset from Pakistan, graded by three specialists according to the severity of Diabetic Retinopathy. The dataset aims to improve research and patient care.

Detailed description

This clinical trial aims to address the scarcity of retinal image datasets in Pakistan by providing a comprehensive digital fundus photograph dataset, accompanied by expert grading. The dataset will encompass retinal images from Pakistani individuals, meticulously labeled by three Vitreo Retinal Specialists. These specialists will assess the presence and severity of common retinal disorders, including No Diabetic Retinopathy (No DR), Mild, Moderate, Severe, Proliferative Diabetic Retinopathy, Clinically Significant Macular Edema (CSME), and Advance diabetic Eye Diseases (ADED). Each image will also be evaluated for diagnostic clarity and the presence of any additional findings. Final grading decisions will be reached through unanimous consensus among the graders, ensuring the dataset's reliability and accuracy. This initiative holds promise for advancing ophthalmic research and improving patient care in Pakistan and beyond.

Interventions

Participants will undergo retinal imaging by fundus camera. Three specialists will independently grade images for common retinal disorders like Diabetic Retinopathy. Final grading decisions will be unanimous among the specialists.

Sponsors

Al-Ibrahim Eye Hospital
CollaboratorOTHER
Pakistan Council of Scientific and Industrial Research
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with Type I or Type II Diabetes. * Patients of age of 20 years or above

Exclusion criteria

* The participant is unable or unwilling to comply with study procedures. * Vulnerable participants (minors, legally detained individuals). * Prisoners or subjects who are involuntarily incarcerated.

Design outcomes

Primary

MeasureTime frameDescription
Grading Diabetic Retinopathy Severity according to International Clinical Diabetic Retinopathy Severity Scale1 Visit (1 day)Each Fundus photograph will be evaluated according to the Severity of Diabetic Retinopathy following International Clinical Diabetic Retinopathy Severity Scale (ICDRSS). Following Diabetic Retinopathy symptoms will be graded according to this scale. 1. No DR 2. Mild 3. Moderate 4. Severe 5. Proliferative
Grading Diabetic Retinopathy Severity according to Early Treatment of Diabetic Retinopathy Scale1 Visit (1 day)Each Fundus photograph will be evaluated according to the Severity of Diabetic Retinopathy following Early Treatment of Diabetic Retinopathy Scale (ETDRS). Following Diabetic Retinopathy symptoms will be graded according to this scale. 1. Clinically Significant Macular Edema 2. Advance Diabetic Eye Disease
Finding inter-rater agreement among the gradersTwo YearsThe intraclass correlation coefficient will be calculated using the collected dataset to assess the consistency in grading among all graders.

Countries

Pakistan

Contacts

Primary ContactGhulam Mustafa
mustafabme@gmail.com+923322340395

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026